These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25198357)
21. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines. Dórea JG Clin Chim Acta; 2010 Nov; 411(21-22):1580-6. PubMed ID: 20638374 [TBL] [Abstract][Full Text] [Related]
22. Pandemic blows lid off laws limiting mercury in vaccines. Schubert C Nat Med; 2010 Jan; 16(1):9. PubMed ID: 20057400 [No Abstract] [Full Text] [Related]
23. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders. Bigham M; Copes R; Srour L Can Commun Dis Rep; 2002 May; 28(9):69-80. PubMed ID: 12012653 [No Abstract] [Full Text] [Related]
24. Preventing harm from thimerosal in vaccines. Offit PA JAMA; 2000 Apr; 283(16):2104; author reply 2105. PubMed ID: 10791498 [No Abstract] [Full Text] [Related]
25. Preventing harm from thimerosal in vaccines. Plotkin SA JAMA; 2000 Apr; 283(16):2104-5. PubMed ID: 10791499 [No Abstract] [Full Text] [Related]
26. Autism and vaccination-the current evidence. Miller L; Reynolds J J Spec Pediatr Nurs; 2009 Jul; 14(3):166-72. PubMed ID: 19614825 [TBL] [Abstract][Full Text] [Related]
27. [On the elimination of multidose vaccines containing thimerosal]. Calvo M Rev Chilena Infectol; 2013 Aug; 30(4):346-9. PubMed ID: 24248102 [No Abstract] [Full Text] [Related]
28. [Addressing the controversy regarding the association between thimerosal-containing vaccines and autism]. García-Fernández L; Hernández AV; Suárez Moreno V; Fiestas F Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):268-74. PubMed ID: 23949514 [TBL] [Abstract][Full Text] [Related]
30. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Ann Pharmacother; 1999 Sep; 33(9):1021. PubMed ID: 10492513 [No Abstract] [Full Text] [Related]
31. The evidence for the safety of thiomersal in newborn and infant vaccines. Clements CJ Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295 [TBL] [Abstract][Full Text] [Related]
32. Association between thimerosal-containing vaccine and autism. Rimland B JAMA; 2004 Jan; 291(2):180; author reply 180-1. PubMed ID: 14722135 [No Abstract] [Full Text] [Related]
33. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Neonatal Netw; 1999 Sep; 18(6):65, 72. PubMed ID: 10690100 [No Abstract] [Full Text] [Related]
34. Vaccines, thimerosal, and neurodevelopmental outcomes. Herman LM; Gerbert DA; Larson LW; Léger MM; McNellis R; O'Donoghue DL; Ulshafer C; Van Dyke EM JAAPA; 2006 Jan; 19(1):16, 18-9. PubMed ID: 16433218 [No Abstract] [Full Text] [Related]
35. Association between thimerosal-containing vaccine and autism. Bernard S JAMA; 2004 Jan; 291(2):180; author reply 180-1. PubMed ID: 14722136 [No Abstract] [Full Text] [Related]
40. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. Geier DA; Sykes LK; Geier MR J Toxicol Environ Health B Crit Rev; 2007 Dec; 10(8):575-96. PubMed ID: 18049924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]